Bitte wählen Sie:

Universitätsklinikum Essen
Direkteinstieg:
Klinik

Direktor der Klinik für Gastroenterologie, Hepatologie und Transplantationsmedizin

 

Prof. Dr. med. Hartmut H.-J. Schmidt ist Direktor der Klinik für Gastroenterologie, Hepatologie und Transplantationsmedizin am Universitätsklinikum Essen.

 

Prof. Dr. Hartmut Schmidt wurde im niedersächsischen Kirchweyhe geboren. Er studierte Medizin in Hannover und am National Institute of Health in Bethesda, USA. Im Jahr 1988 nahm er seine klinische Tätigkeit an der Medizinischen Hochschule in Hannover in der Abteilung für Gastroenterologie auf und absolvierte einen zweijährigen Forschungsaufenthalt im Rahmen eines Stipendiums der Deutschen Forschungsgemeinschaft am National Institute of Health in Bethesda.

Neben dem Facharzt für Innere Medizin führt Prof. Dr. Hartmut Schmidt die Weiterbildung im Fach Gastroenterologie und die Zusatzbezeichnung Rettungsmedizin und Ernährungsmedizin. 1999 bis 2005 war Prof. Schmidt als Oberarzt, zuletzt als leitender Oberarzt an der Berliner Charité in der Medizinischen Klinik für Gastroenterologie, Hepatologie und Endokrinologie tätig. In 2005 nahm er den Ruf auf eine Professur für Experimentelle Transplantationshepatologie an der Medizinischen Fakultät der Universität Münster an, leitete später eine Sektion Klinische Transplantationshepatologie. In 2010 etablierte er eine Klinik für Transplantationsmedizin mit hepatologischem Schwerpunkt in Münster, seit 2017 war er dort Direktor der Medizinischen Klinik B (Gastroenterologie, Hepatologie, Endokrinologie, Klinische Infektiologie). Für seine wissenschaftlichen Aktivitäten erhielt er unter anderem zweimal den Präventionspreis der Deutschen Gesellschaft für Innere Medizin (1996 und 2001), den Ludolph-Brauer-Preis der Nordwestdeutschen Gesellschaft für Innere Medizin (1998) sowie den Forschungspreis für Transplantation der Deutschen Transplantationsgesellschaft (1998).

Zum 1. Mai 2021 übernahm Prof. Dr. Hartmut Schmidt den Lehrstuhl für Innere Medizin, Schwerpunkt Gastroenterologie und Hepatologie, an der Medizinischen Fakultät der Universität Duisburg-Essen und die damit verbundene Position des Direktors der Klinik für Gastroenterologie und Hepatologie an der Universitätsmedizin Essen.

 

in Bearbeitung

Kessel C, Vollenberg R, Masjosthusmann K, Hinze C, Wittkowski H, Debaugnies F, Nagant C, Corazza F, Vély F, Kaplanski G, Girard-Guyonvarc'h C, Gabay C, Schmidt H, Foell D, Tepasse PR. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers. Arthritis Rheumatol. 2021 Oct;73(10):1791-1799.

Oertel M, Gattermann F, Schmidt H, Eich HT. Examining the Use of Radiation Therapy for Cholangiocarcinoma: Benefits through Modern Techniques. Oncol Res Treat. 2021;44(7-8):408-413.

Bezerra F, Niemietz C, Schmidt HHJ, Zibert A, Guo S, Monia BP, Gonçalves P, Saraiva MJ, Almeida MR. In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis. Int J Mol Sci. 2021 Aug 31;22(17):9488.

Jörrißen P, Schütz P, Weiand M, Vollenberg R, Schrempf IM, Ochs K, Frömmel C, Tepasse PR, Schmidt H, Zibert A. Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19. Front Immunol. 2021 Aug 4;12:679841.

Bolte FJ, Schmidt HH, Schlevogt B. Immune-Mediated Hepatitis Induced by Therapy With Alemtuzumab in a Patient With Multiple Sclerosis. Hepatology 2021;73:460-463.

Eichelmann AK, Vogel T, Fuchs AK, Houben P, Katou S, Becker F, Schmidt HH, Wilms C, Pascher A, Brockmann JG. Short- and Long-Term Outcomes of Different Reperfusion Sequences in Liver Transplantation. Ann Transplant. 2021 Feb 19;26:e926847.

Masthoff M, Schindler P, Harders F, Heindel W, Wilms C, Schmidt HH, Pascher A, Stegger L, Rahbar K, Köhler M, Wildgruber M. Analysis of failed therapy evaluations in radioembolization of primary and secondary liver cancers. J Cancer Res Clin Oncol 2021;147:1537-1545.

Minnebeck K, Vorona E, Zinn S, Gellner R, Hinder J, Brand SM, Kabar I, Alten F, Schmitz B. Four weeks of high-intensity interval training (HIIT) improve the cardiometabolic risk profile of overweight patients with type 1 diabetes mellitus (T1DM). Eur J Sport Sci 2021;21:1193-1203.

Adams D, Gonzalez-Duarte A, Mauricio E, Brannagan T, Coelho T, Wixner J, Schmidt H, Berber E, Sweetser M, White M, Wang JJ, Polydefkis M. Global Open-label Extension: 24-month Data of Patisiran in Patients with hATTR Amyloidosis. Journal of the Peripheral Nervous System 2020;25:524-525.

Bettenworth D, Bokemeyer A, Kou L, Lopez R, Bena JF, El Ouali S, Mao R, Kurada S, Bhatt A, Beyna T, Halloran B, Reeson M, Hosomi S, Kishi M, Hirai F, Ohmiya N, Rieder F. Systematic review with meta-analysis: efficacy of balloon-assisted enteroscopy for dilation of small bowel Crohn's disease strictures. Aliment Pharmacol Ther 2020;52:1104-1116.

Bokemeyer A, Gerges C, Lang D, Bettenworth D, Kabar I, Schmidt H, Neuhaus H, Ullerich H, Lenze F, Beyna T. Digital single-operator video cholangioscopy in treating refractory biliary stones: a multicenter observational study. Surg Endosc 2020;34:1914-1922.

Bokemeyer A, Ochs K, Fuhrmann V. [Acute Abdomen: Diagnostic Management]. Dtsch Med Wochenschr 2020;145:1544-1551.

Bolte FJ, Langenstroer C, Friebel F, Hüsing-Kabar A, Dugas M, Schmidt HH. Patient-reported outcomes on familial amyloid polyneuropathy (FAP). Orphanet J Rare Dis 2020;15:287.

Brannagan TH, Wang AK, Coelho T, Waddington Cruz M, Polydefkis MJ, Dyck PJ, Plante-Bordeneuve V, Berk JL, Barroso F, Merlini G, Conceição I, Hughes SG, Kwoh J, Jung SW, Guthrie S, Pollock M, Benson MD, Gertz M, NEURO-TTR open-label extension investigators. Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial. Eur J Neurol 2020;27:1374-1381.

Coelho T, Adams D, Conceição I, Waddington-Cruz M, Schmidt HH, Buades J, Campistol J, Berk JL, Polydefkis M, Wang JJ, Chen J, Sweetser MT, Gollob J, Suhr OB. A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis. Orphanet J Rare Dis 2020;15:179.

Coelho T, Gillmore J, Adams D, Munoz-Beamud F, Mazzeo A, Wixner J, Plante-Bordeneuve V, Llado L, Arum S, Wang JJ, Li XY, Schmidt H. Open-label study of Patisiran in patients with hATTR amyloidosis post-orthotopic liver transplant. Journal of the Peripheral Nervous System 2020;25:526-526.

Coelho T, Yarlas A, Waddington-Cruz M, White MK, Sikora Kessler A, Lovley A, Pollock M, Guthrie S, Ackermann EJ, Hughes SG, Karam C, Khella S, Gertz M, Merlini G, Obici L, Schmidt HH, Polydefkis M, Dyck PJB, Brannagan Iii TH, Conceição I, Benson MD, Berk JL. Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis. J Neurol 2020;267:1070-1079.

Cordes F, Demmig C, Bokemeyer A, Brückner M, Lenze F, Lenz P, Nowacki T, Tepasse P, Schmidt HH, Schmidt MA, Cichon C, Bettenworth D. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease. Clin Transl Gastroenterol 2020;11:e00134.

Cordes F, Foell D, Ding JN, Varga G, Bettenworth D. Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease. World J Gastroenterol 2020;26:4055-4075.

Cordes F, Lenker E, Spille LJ, Weinhage T, Bettenworth D, Kessel C, Schmidt HH, Foell D, Varga G. Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype. Inflamm Bowel Dis 2020;26:391-406.

Derer S, Brethack AK, Pietsch C, Jendrek ST, Nitzsche T, Bokemeyer A, Hov JR, Schäffler H, Bettenworth D, Grassl GA, Sina C. Inflammatory Bowel Disease-associated GP2 Autoantibodies Inhibit Mucosal Immune Response to Adherent-invasive Bacteria. Inflamm Bowel Dis 2020;26:1856-1868.

Dugas M, Schrempf IM, Ochs K, Frömmel C, Greulich L, Neuhaus P, Tepasse PR, Schmidt HH. Association of contact to small children with a mild course of COVID-19. Int J Infect Dis 2020;100:314-315.

Ebel F, Deterding K, Port K, Schlevogt B, Manns MP, Maasoumy B, Cornberg M, Wedemeyer H. Letter: a 5-year long-term follow-up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis. Aliment Pharmacol Ther 2020;51:194-195.

Elsayad K, Reinartz G, Oertel M, Rehn S, Eismann J, Scobioala S, Berssenbrügge H, Eter N, Weishaupt C, Schmidt HH, Friedrichs B, Grünewald I, Hartmann W, Lenz G, Wardelmann E, Willich N, Eich HT. Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients. Strahlenther Onkol 2020;196:117-125.

Falls-Hubert KC, Butler AL, Gui K, Anderson M, Li M, Stolwijk JM, Rodman SN, 3rd, Solst SR, Tomanek-Chalkley A, Searby CC, Sheffield VC, Sandfort V, Schmidt H, McCormick ML, Wels BR, Allen BG, Buettner GR, Schultz MK, Spitz DR. Disulfiram causes selective hypoxic cancer cell toxicity and radio-chemo-sensitization via redox cycling of copper. Free Radic Biol Med 2020;150:1-11.

Florian A, Bietenbeck M, Chatzantonis G, Hüsing-Kabar A, Schmidt H, Yilmaz A. Regression of cardiac amyloid load documented by cardiovascular magnetic resonance in a patient with hereditary amyloidosis. Clin Res Cardiol 2020;109:949-956.

Fuhrmann V, Bauer M, Wilmer A. The persistent potential of extracorporeal therapies in liver failure. Intensive Care Med 2020;46:528-530.

Fuhrmann V, Weber T, Roedl K, Motaabbed J, Tariparast A, Jarczak D, de Garibay APR, Kluwe J, Boenisch O, Herkner H, Kellum JA, Kluge S. Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure. Ann Intensive Care 2020;10:96.

Garcia-Tsao G, Bosch J, Kayali Z, Harrison SA, Abdelmalek MF, Lawitz E, Satapathy SK, Ghabril M, Shiffman ML, Younes ZH, Thuluvath PJ, Berzigotti A, Albillos A, Robinson JM, Hagerty DT, Chan JL, Sanyal AJ, IDN-6556-14 Investigators. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension. J Hepatol 2020;72:885-895.

Gillessen A, Schmidt HH. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. Adv Ther 2020;37:1279-1301.

González-Duarte A, Berk JL, Quan D, Mauermann ML, Schmidt HH, Polydefkis M, Waddington-Cruz M, Ueda M, Conceição IM, Kristen AV, Coelho T, Cauquil CA, Tard C, Merkel M, Aldinc E, Chen J, Sweetser MT, Wang JJ, Adams D. Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. J Neurol 2020;267:703-712.

González-Duarte A, Berk JL, Quan D, Mauermann ML, Schmidt HH, Polydefkis M, Waddington-Cruz M, Ueda M, Conceição IM, Kristen AV, Coelho T, Cauquil CA, Tard C, Merkel M, Aldinc E, Chen J, Sweetser MT, Wang JJ, Adams D. Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. J Neurol 2020;267:713-714.

Gordon IO, Bettenworth D, Bokemeyer A, Srivastava A, Rosty C, de Hertogh G, Robert ME, Valasek MA, Mao R, Kurada S, Harpaz N, Borralho P, Pai RK, Pai RK, Odze R, Feakins R, Parker CE, Nguyen T, Jairath V, Baker ME, Bruining DH, Fletcher JG, Feagan BG, Rieder F. Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review. Gastroenterology 2020;158:137-150.e1.

Grensemann J, Busse D, König C, Roedl K, Jäger W, Jarczak D, Iwersen-Bergmann S, Manthey C, Kluge S, Kloft C, Fuhrmann V. Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study. Ann Intensive Care 2020;10:48.

Guttmann S, Nadzemova O, Grünewald I, Lenders M, Brand E, Zibert A, Schmidt HH. ATP7B knockout disturbs copper and lipid metabolism in Caco-2 cells. PLoS One 2020;15:e0230025.

Jehn U, Schütte-Nütgen K, Bautz J, Pavenstädt H, Suwelack B, Thölking G, Heinzow H, Reuter S. Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation. J Clin Med 2020;9:252.

Joannidis M, Forni LG, Klein SJ, Honore PM, Kashani K, Ostermann M, Prowle J, Bagshaw SM, Cantaluppi V, Darmon M, Ding X, Fuhrmann V, Hoste E, Husain-Syed F, Lubnow M, Maggiorini M, Meersch M, Murray PT, Ricci Z, Singbartl K, Staudinger T, Welte T, Ronco C, Kellum JA. Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive Care Med 2020;46:654-672.

Kampmeier S, Rennebaum F, Schmidt H, Riegel A, Herrmann M, Schaumburg F. Peripancreatic abscess supported by Bordetella hinzii. New Microbes New Infect 2020;34:100650.

Kneifel F, Becker F, Flammang I, Katou S, Vogel T, Radunz S, Houben P, Schmidt H, Pascher A, Brockmann J. The Munster Machine Experience: Fifteen Liver Transplants Following Normothermic Perfusion. Transplant International 2020;33:35-36.

Knop V, Mauss S, Goeser T, Geier A, Zimmermann T, Herzer K, Postel N, Friedrich-Rust M, Hofmann WP, German Hepatitis C-Registry. Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy-Results from the German Hepatitis C-Registry. J Viral Hepat 2020;27:690-698.

Lenze F, Nowacki T, Schöppner S, Ullerich H, Bettenworth D, Soriani P, Gabbani T, Mirante VG, Domagk D, Manno M, Lenz P. Bowel Preparation With Polyethylene Glycol 3350 or Fasting Only Before Peroral Single-balloon Enteroscopy: A Randomized European Multicenter Trial. J Clin Gastroenterol 2020;54:170-174.

Masthoff M, Schindler P, Harders F, Heindel W, Wilms C, Schmidt HH, Pascher A, Stegger L, Rahbar K, Wildgruber M, Köhler M. Repeated radioembolization in advanced liver cancer. Ann Transl Med 2020;8:1055.

Meier JA, Bokemeyer A, Cordes F, Fuhrmann V, Schmidt H, Hüsing-Kabar A, Kabar I. Serum levels of ferritin and transferrin serve as prognostic factors for mortality and survival in patients with end-stage liver disease: A propensity score-matched cohort study. United European Gastroenterol J 2020;8:332-339.

Niemietz C, Bezerra F, Almeida MR, Guo S, Monia BP, Saraiva MJ, Schütz P, Schmidt HH, Zibert A. SERPINA1 modulates expression of amyloidogenic transthyretin. Exp Cell Res 2020;395:112217.

Niemietz C, Nadzemova O, Zibert A, Schmidt HH. APOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNA. Amyloid 2020;27:45-51.

Obici L, Berk JL, González-Duarte A, Coelho T, Gillmore J, Schmidt HH, Schilling M, Yamashita T, Labeyrie C, Brannagan TH, 3rd, Ajroud-Driss S, Gorevic P, Kristen AV, Franklin J, Chen J, Sweetser MT, Wang JJ, Adams D. Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. Amyloid 2020;27:153-162.

Pöhler M, Guttmann S, Nadzemova O, Lenders M, Brand E, Zibert A, Schmidt HH, Sandfort V. CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B. PLoS One 2020;15:e0239411.

Polydefkis M, Gonzalez-Duarte A, Coelho T, Wixner J, Kristen A, Schmidt H, Berk JL, Berber E, Sweetser M, White M, Wang JJ, Adams D. Long-term Safety and Efficacy of Patisiran in Patients with hATTR Amyloidosis: Global OLE Study. Neurology 2020;94:3.

Reinartz G, Molavi Tabrizi C, Liersch R, Ullerich H, Hering D, Willborn K, Schultze J, Micke O, Ruebe C, Fischbach W, Bentz M, Daum S, Pott C, Tiemann M, Moeller P, Neubauer A, Wilhelm M, Lenz G, Berdel WE, Willich N, Eich HT. Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials. Oncologist 2020;25:e816-e832.

Reintam Blaser A, Preiser JC, Fruhwald S, Wilmer A, Wernerman J, Benstoem C, Casaer MP, Starkopf J, van Zanten A, Rooyackers O, Jakob SM, Loudet CI, Bear DE, Elke G, Kott M, Lautenschläger I, Schäper J, Gunst J, Stoppe C, Nobile L, Fuhrmann V, Berger MM, Oudemans-van Straaten HM, Arabi YM, Deane AM. Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care Medicine. Crit Care 2020;24:224.

Rössle M, Bettinger D, Trebicka J, Klinger C, Praktiknjo M, Sturm L, Caca K, Mücke VT, Radecke K, Engelmann C, Zipprich A, Heinzow H, Meyer C, Tappe U, Appenrodt B, Schmidt A, Lange C, Strassburg C, Zeuzem S, Grandt D, Schmidt H, Moessner J, Berg T, Lammert F, Thimme R, Schultheiß M. A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatment. Aliment Pharmacol Ther 2020;52:329-339.

Schäfer-Graf U, Laubner K, Hummel S, Gembruch U, Groten T, Kainer F, Grieshop M, Bancher-Todesca D, Cervar-Zivakovic M, Hösli I, Kaltheuner M, Gellner R, Kautzky-Willer A, Bührer C, Patchev V, Nothacker M. Gestational diabetes mellitus (GDM), diagnostics, therapy and aftercare Practice Recommendation-Abstract of the S3 Guideline (AWMF Register Number: 057-008). Diabetologe 2020;16:362-372.

Schäfer-Graf U, Laubner K, Hummel S, Gembruch U, Groten T, Kainer F, Grieshop M, Bancher-Todesca D, Cervar-Zivakovic M, Hösli I, Kaltheuner M, Gellner R, Kautzky-Willer A, Bührer C, Patchev V, Nothacker M. Gestational Diabetes mellitus (GDM), Diagnostics, Therapy and Aftercare Practical Recommendation - Outline of the S3-Guideline (AWMF Register Number: 057-008). Diabetologie Und Stoffwechsel 2020;15:S101-S111.

Schindler P, Heinzow H, Trebicka J, Wildgruber M. Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges. J Clin Med 2020;9:3784.

Schindler P, Seifert L, Masthoff M, Riegel A, Köhler M, Wilms C, Schmidt HH, Heinzow H, Wildgruber M. TIPS Modification in the Management of Shunt-Induced Hepatic Encephalopathy: Analysis of Predictive Factors and Outcome with Shunt Modification. J Clin Med 2020;9:567.

Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwoppe C, Wildgruber M, Hansmeier A, Angenendt L, Berdel AF, Kessler T, Wilms C, Hartmann W, Wardelmann E, Kraehling T, Heindel W, Gerss J, Schmidt H, Lenz G, Mesters R, Berdel WE. First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study. Annals of Oncology 2020;31:S485-S485.

Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Stalmann U, Berning B, Kratz-Albers K, Middelberg-Bisping K, Wiebe S, Albring J, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Bormann E, Schmidt H, Lenz G, Kessler T, Mesters RM, Berdel WE. First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study. Cancers (Basel) 2020;12:1488.

Tepasse PR, Hafezi W, Lutz M, Kühn J, Wilms C, Wiewrodt R, Sackarnd J, Keller M, Schmidt HH, Vollenberg R. Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature. Br J Haematol 2020;190:185-188.

Troschel AS, Miks A, Hüsing-Kabar A, Heinzow HS, Schmidt HH, Troschel FM, Kabar I. Inflammation, etiologies and Model for End-stage Liver Disease score: What makes liver disease patients susceptible to developing colorectal neoplasia? Hepatol Res 2020;50:342-352.

von Einsiedel J, Thölking G, Wilms C, Vorona E, Bokemeyer A, Schmidt HH, Kabar I, Hüsing-Kabar A. Conversion from Standard-Release Tacrolimus to MeltDose(®) Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation. J Clin Med 2020;9:1654.

von Schnurbein J, Adams C, Akinci B, Ceccarini G, D'Apice MR, Gambineri A, Hennekam RCM, Jeru I, Lattanzi G, Miehle K, Nagel G, Novelli G, Santini F, Santos Silva E, Savage DB, Sbraccia P, Schaaf J, Sorkina E, Tanteles G, Vantyghem MC, Vatier C, Vigouroux C, Vorona E, Araújo-Vilar D, Wabitsch M. European lipodystrophy registry: background and structure. Orphanet J Rare Dis 2020;15:17.

Wennmann DO, Dlugos CP, Hofschröer A, Hennies M, Kühn J, Hafezi W, Kampmeier S, Mellmann A, Triphaus S, Sackarnd J, Tepasse P, Keller M, Van Aken H, Pavenstädt H, Kümpers P. [Handling of COVID-19 in the emergency department : Field report of the emergency ward of the University Hospital Münster]. Med Klin Intensivmed Notfmed 2020;115:380-387.

Zinn S, Nelis P, Minnebeck K, Hinder J, Eter N, Brand SM, Gellner R, Vorona E, Alten F, Schmitz B. Effect of high-intensity interval training in patients with type 1 diabetes on physical fitness and retinal microvascular perfusion determined by optical coherence tomography angiography. Microvasc Res 2020;132:104057.

Bokemeyer A, Gross D, Brückner M, Nowacki T, Bettenworth D, Schmidt H, Heinzow H, Kabar I, Ullerich H, Lenze F. Digital single-operator cholangioscopy: a useful tool for selective guidewire placements across complex biliary strictures. Surg Endosc 2019;33:731-737.

Bokemeyer A, Matern P, Bettenworth D, Cordes F, Nowacki TM, Heinzow H, Kabar I, Schmidt H, Ullerich H, Lenze F. Endoscopic Radiofrequency Ablation Prolongs Survival of Patients with Unresectable Hilar Cholangiocellular Carcinoma - A Case-Control Study. Sci Rep 2019;9:13685.

Bürger C, Maschmeier M, Hüsing-Kabar A, Wilms C, Köhler M, Schmidt M, Schmidt HH, Kabar I. Achieving Complete Remission of Hepatocellular Carcinoma: A Significant Predictor for Recurrence-Free Survival after Liver Transplantation. Can J Gastroenterol Hepatol 2019;2019:5796074.

Cordes F, Ellermann C, Dechering DG, Frommeyer G, Kochhäuser S, Lange PS, Pott C, Lenze F, Schmidt H, Ullerich H, Eckardt L. Time-to-isolation-guided cryoballoon ablation reduces oesophageal and mediastinal alterations detected by endoscopic ultrasound: results of the MADE-PVI trial. Europace 2019;21:1325-1333.

Cordes F, Laumeyer T, Gerß J, Brückner M, Lenze F, Nowacki T, Rijcken E, Tepasse P, Schmidt H, Kucharzik T, Bettenworth D. Distinct Disease Phenotype of Ulcerative Colitis in Patients With Coincident Primary Sclerosing Cholangitis: Evidence From a Large Retrospective Study With Matched Cohorts. Dis Colon Rectum 2019;62:1494-1504.

Gerwing M, Wilms C, Heinzow H, Sporns PB, Heindel W, Schmidt H, Wildgruber M, Köhler M. Escalating interventional recanalization therapy in non-cirrhotic, non-malignant acute portal vein thrombosis. Eur J Gastroenterol Hepatol 2019;31:1584-1591.

Guttmann S, Dewald ET, Wohlfarth C, Müller JC, Karst U, Schmidt HH, Zibert A. Compound-specific adaptation of hepatoma cell lines to toxic iron. Metallomics 2019;11:1836-1846.

Herden U, Schoening W, Pratschke J, Manekeller S, Paul A, Linke R, Lorf T, Lehner F, Braun F, Stippel DL, Sucher R, Schmidt H, Strassburg CP, Guba M, van Rosmalen M, Rogiers X, Samuel U, Schön GM, Nashan B. Accuracy of Pretransplant Imaging Diagnostic for Hepatocellular Carcinoma: A Retrospective German Multicenter Study. Can J Gastroenterol Hepatol 2019;2019:8747438.

Köhler M, Harders F, Lohöfer F, Paprottka PM, Schaarschmidt BM, Theysohn J, Herrmann K, Heindel W, Schmidt HH, Pascher A, Stegger L, Rahbar K, Wildgruber M. Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization. J Clin Med 2019;9:56.

Lenders M, Stappers F, Niemietz C, Schmitz B, Boutin M, Ballmaier PJ, Zibert A, Schmidt H, Brand SM, Auray-Blais C, Brand E. Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy. J Med Genet 2019;56:548-556.

Mihailovic N, Bartel CC, Rosenberger F, Brücher VC, Eter N, Beyer T, Schmidt H, Uhlig CE. Attitudes and Knowledge Regarding Postmortem Cornea Donation among Young and Elderly People in Germany: Sufficient for Decision Making? Ophthalmic Res 2019;62:173-184.

Polishchuk EV, Merolla A, Lichtmannegger J, Romano A, Indrieri A, Ilyechova EY, Concilli M, De Cegli R, Crispino R, Mariniello M, Petruzzelli R, Ranucci G, Iorio R, Pietrocola F, Einer C, Borchard S, Zibert A, Schmidt HH, Di Schiavi E, Puchkova LV, Franco B, Kroemer G, Zischka H, Polishchuk RS. Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis. Gastroenterology 2019;156:1173-1189.e5.

Schlevogt B, Kinast V, Reusch J, Kerkhoff A, Praditya D, Todt D, Schmidt HH, Steinmann E, Behrendt P. Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment. Pathogens 2019;8:129.

Troschel AS, Miks A, Troschel FM, Hüsing-Kabar A, Maschmeier M, Heinzow HS, Schmidt HH, Kabar I. Chronic liver disease promotes lesions of the colorectal adenoma-carcinoma sequence, independent of liver cirrhosis. United European Gastroenterol J 2019;7:662-672.

Waddington-Cruz M, Schmidt H, Botteman MF, Carter JA, Stewart M, Hopps M, Fallet S, Amass L. Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series. Orphanet J Rare Dis 2019;14:34.

Zibert A, Hüsing-Kabar A, Schmidt H. [Current approaches for treatment of hereditary transthyretin amyloidosis (ATTR)]. Dtsch Med Wochenschr 2019;144:1438-1443.

Dogan N, Hüsing-Kabar A, Schmidt HH, Cicinnati VR, Beckebaum S, Kabar I. Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure. J Int Med Res 2018;46:3979-3990.

Herzer K, Gerken G, Kroy D, Tacke F, Plewe J, Eurich D, Spengler U, Strassburg CP, Welker MW, Pischke S, Sterneck M, Mehrabi A, Weiss KH, Herber A, Berg T, Zimmermann T, Galle PR, Heinzow H, Schmidt H, Markova A, Serfert Y, Manns MP, Zeuzem S, Wedemeyer H. Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany. J Hepatol 2018;69:982-984.

Kabar I, Hüsing-Kabar A, Maschmeier M, Völler C, Dümke M, Schmidt HH, Heinzow H. Pictorial Representation of Illness and Self Measure (PRISM): A Novel Visual Instrument to Quantify Suffering in Liver Cirrhosis Patients and Liver Transplant Recipients. Ann Transplant 2018;23:674-680.

Kara D, Hüsing-Kabar A, Schmidt H, Grünewald I, Chandhok G, Maschmeier M, Kabar I. Portal Hypertensive Polyposis in Advanced Liver Cirrhosis: The Unknown Entity? Can J Gastroenterol Hepatol 2018;2018:2182784.

Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C, ATTR-ACT Study Investigators. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med 2018;379:1007-1016.

Niemietz C, Fleischhauer L, Sandfort V, Guttmann S, Zibert A, Schmidt HH. Hepatocyte-like cells reveal novel role of SERPINA1 in transthyretin amyloidosis. J Cell Sci 2018;131:jcs219824.

Prof. Dr. med. Hartmut Schmidt

Prof. Dr. med. Hartmut Schmidt

Direktor der Klinik für Gastroenterologie, Hepatologie und Transplantationsmedizin

+49 201 723 3610 +49 201 723 5971 E-Mail schreiben Zum Steckbrief
 Angelika Lammers
Sekretariat

Angelika Lammers

Sekretariat des Klinikdirektors Prof. Dr. Hartmut Schmidt

+49 201 723 3610/ 3611 +49 201 723 5971 E-Mail schreiben